{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:16:23Z","timestamp":1781990183130,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00508-023-02208-1","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:02:12Z","timestamp":1685628132000},"page":"154-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of a\u00a0protein kinase\u00a0B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization"],"prefix":"10.1007","volume":"136","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-5258","authenticated-orcid":false,"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"2208_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2007.08.014","author":"DC Beebe","year":"2008","unstructured":"Beebe\u00a0DC. Maintaining transparency: a\u00a0review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol. 2008; https:\/\/doi.org\/10.1016\/j.semcdb.2007.08.014.","journal-title":"Semin Cell Dev Biol"},{"key":"2208_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee\u00a0P, Wang\u00a0CC, Adamis\u00a0AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245\u201369. https:\/\/doi.org\/10.1016\/s0039-6257(98)00035-6.","journal-title":"Surv Ophthalmol"},{"key":"2208_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3980\/j.issn.2222-3959.2015.01.32","volume":"8","author":"NS Abdelfattah","year":"2015","unstructured":"Abdelfattah\u00a0NS, Amgad\u00a0M, Zayed\u00a0AA, et\u00a0al. Clinical correlates of common corneal neovascular diseases: a\u00a0literature review. Int J Ophthalmol. 2015;8:182\u201393. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.01.32.","journal-title":"Int J Ophthalmol"},{"key":"2208_CR4","first-page":"911","volume":"5","author":"PM Cherry","year":"1973","unstructured":"Cherry\u00a0PM, Faulkner\u00a0JD, Shaver\u00a0RP, et\u00a0al. Argon laser treatment of corneal neovascularization. Ann Ophthalmol. 1973;5:911\u201320.","journal-title":"Ann Ophthalmol"},{"key":"2208_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archopht.1975.01010020797012","volume":"93","author":"JW Reed","year":"1975","unstructured":"Reed\u00a0JW, Fromer\u00a0C, Klintworth\u00a0GK. Induced corneal vascularization remission with argon laser therapy. Arch Ophthalmol. 1975;93:1017\u20139. https:\/\/doi.org\/10.1001\/archopht.1975.01010020797012.","journal-title":"Arch Ophthalmol"},{"key":"2208_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/lsm.1900080503","volume":"8","author":"CJ Gomer","year":"1988","unstructured":"Gomer\u00a0CJ, Ferrario\u00a0A, Hayashi\u00a0N, et\u00a0al. Molecular, cellular, and tissue responses following photodynamic therapy. Lasers Surg Med. 1988;8:450\u201363. https:\/\/doi.org\/10.1002\/lsm.1900080503.","journal-title":"Lasers Surg Med"},{"key":"2208_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.exer.2018.03.010","volume":"171","author":"A Gore","year":"2018","unstructured":"Gore\u00a0A, Horwitz\u00a0V, Cohen\u00a0M, et al. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model. Exp Eye Res. 2018;171:183\u201391. https:\/\/doi.org\/10.1016\/j.exer.2018.03.010.","journal-title":"Exp Eye Res"},{"key":"2208_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/tvst.12.3.28","volume":"12","author":"JS Peterson","year":"2023","unstructured":"Peterson\u00a0JS, Chen\u00a0W, Libin\u00a0BM, et\u00a0al. Sustained ocular delivery of bevacizumab using densomeres in rabbits: effects on molecular integrity and bioactivity. Transl Vis Sci Technol. 2023;12:28. https:\/\/doi.org\/10.1167\/tvst.12.3.28.","journal-title":"Transl Vis Sci Technol"},{"key":"2208_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.sjopt.2017.02.008","volume":"31","author":"T Al-Debasi","year":"2017","unstructured":"Al-Debasi\u00a0T, Al-Bekairy\u00a0A, Al-Katheri\u00a0A, et al. Topical versus subconjunctival anti-vascular endothelial growth factor therapy (bevacizumab, ranibizumab and aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol. 2017;31:99\u2013105. https:\/\/doi.org\/10.1016\/j.sjopt.2017.02.008.","journal-title":"Saudi J Ophthalmol"},{"key":"2208_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-023-02685-3","author":"M Celenk","year":"2023","unstructured":"Celenk\u00a0M, Yildirim\u00a0H, Tektemur\u00a0A, et\u00a0al. Effect of topical motesanib in experimental corneal neovascularization model. Int Ophthalmol. 2023; https:\/\/doi.org\/10.1007\/s10792-023-02685-3.","journal-title":"Int Ophthalmol"},{"key":"2208_CR11","doi-asserted-by":"publisher","first-page":"122682","DOI":"10.1016\/j.ijpharm.2023.122682","volume":"635","author":"L Gomes Souza","year":"2023","unstructured":"Gomes Souza\u00a0L, Antonio Sousa-Junior\u00a0A, Alves Santana Cintra\u00a0B, et al. Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targeting corneal neovascularization. Int J Pharm. 2023;635:122682. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122682.","journal-title":"Int J Pharm"},{"key":"2208_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0092-8674(95)90534-0","volume":"81","author":"TF Franke","year":"1995","unstructured":"Franke\u00a0TF, Yang\u00a0SI, Chan\u00a0TO, et al. The protein kinase encoded by the Akt proto-oncogene is a\u00a0target of the PDGF-activated phosphatidylinositol 3\u2011kinase. Cell. 1995;81:727\u201336. https:\/\/doi.org\/10.1016\/0092-8674(95)90534-0.","journal-title":"Cell"},{"key":"2208_CR13","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1126\/science.275.5308.1899","volume":"275","author":"BA Hemmings","year":"1997","unstructured":"Hemmings\u00a0BA. PH domains\u2014a universal membrane adapter. Science. 1997;275:1899. https:\/\/doi.org\/10.1126\/science.275.5308.1899.","journal-title":"Science"},{"key":"2208_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1126\/science.277.5325.534","volume":"277","author":"BA Hemmings","year":"1997","unstructured":"Hemmings\u00a0BA. PtdIns(3,4,5)P3 gets its message across. Science. 1997;277:534. https:\/\/doi.org\/10.1126\/science.277.5325.534.","journal-title":"Science"},{"key":"2208_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.exer.2019.03.006","volume":"184","author":"J Chen","year":"2019","unstructured":"Chen\u00a0J, Li\u00a0F, Xu\u00a0Y, et al. Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition. Exp Eye Res. 2019;184:64\u201371. https:\/\/doi.org\/10.1016\/j.exer.2019.03.006.","journal-title":"Exp Eye Res"},{"key":"2208_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI9419","volume":"106","author":"Z Luo","year":"2000","unstructured":"Luo\u00a0Z, Fujio\u00a0Y, Kureishi\u00a0Y, et al. Acute modulation of endothelial Akt\/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J\u00a0Clin Invest. 2000;106:493\u20139. https:\/\/doi.org\/10.1172\/JCI9419.","journal-title":"J Clin Invest"},{"key":"2208_CR17","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos\u00a0A, Garcia-Cardena\u00a0G, Madri\u00a0JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J\u00a0Clin Invest. 1997;100:3131\u20139. https:\/\/doi.org\/10.1172\/JCI119868.","journal-title":"J Clin Invest"},{"key":"2208_CR18","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1172\/JCI1560","volume":"101","author":"T Murohara","year":"1998","unstructured":"Murohara\u00a0T, Asahara\u00a0T, Silver\u00a0M, et\u00a0al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J\u00a0Clin Invest. 1998;101:2567\u201378. https:\/\/doi.org\/10.1172\/JCI1560.","journal-title":"J Clin Invest"},{"key":"2208_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-5751-5-8","volume":"5","author":"I Berger","year":"2006","unstructured":"Berger\u00a0I, Stahl\u00a0S, Rychkova\u00a0N, et\u00a0al. VEGF receptors on PC12\u00a0cells mediate transient activation of ERK1\/2 and Akt: comparison of nerve growth factor and vascular endothelial growth factor. J\u00a0Negat Results BioMed. 2006;5:8. https:\/\/doi.org\/10.1186\/1477-5751-5-8.","journal-title":"J Negat Results BioMed"},{"key":"2208_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1267\/ahc.10038","volume":"44","author":"P Wang","year":"2011","unstructured":"Wang\u00a0P, Tian\u00a0XF, Rong\u00a0JB, et al. Protein kinase B (akt) promotes pathological angiogenesis in murine model of oxygen-induced retinopathy. Acta Histochem Cytochem. 2011;44:103\u201311. https:\/\/doi.org\/10.1267\/ahc.10038.","journal-title":"Acta Histochem Cytochem"},{"key":"2208_CR21","doi-asserted-by":"publisher","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber\u00a0HP, McMurtrey\u00a0A, Kowalski\u00a0J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation. J\u00a0Biol Chem. 1998;273:30336\u201343. https:\/\/doi.org\/10.1074\/jbc.273.46.30336.","journal-title":"J Biol Chem"},{"key":"2208_CR22","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1128\/MCB.19.7.5073","volume":"19","author":"Y Fujio","year":"1999","unstructured":"Fujio\u00a0Y, Guo\u00a0K, Mano\u00a0T, et\u00a0al. Cell cycle withdrawal promotes myogenic induction of Akt, a\u00a0positive modulator of myocyte survival. Mol Cell Biol. 1999;19:5073\u201382. https:\/\/doi.org\/10.1128\/MCB.19.7.5073.","journal-title":"Mol Cell Biol"},{"key":"2208_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.cir.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio\u00a0Y, Nguyen\u00a0T, Wencker\u00a0D, et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660\u20137. https:\/\/doi.org\/10.1161\/01.cir.101.6.660.","journal-title":"Circulation"},{"key":"2208_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.14670\/HH-19.915","volume":"19","author":"M Zhan","year":"2004","unstructured":"Zhan\u00a0M, Han\u00a0ZC. Phosphatidylinositide 3\u2011kinase\/AKT in radiation responses. Histol Histopathol. 2004;19:915\u201323. https:\/\/doi.org\/10.14670\/HH-19.915.","journal-title":"Histol Histopathol"},{"key":"2208_CR25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/nm1307","volume":"11","author":"J Chen","year":"2005","unstructured":"Chen\u00a0J, Somanath\u00a0PR, Razorenova\u00a0O, et\u00a0al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11:1188\u201396. https:\/\/doi.org\/10.1038\/nm1307.","journal-title":"Nat Med"},{"key":"2208_CR26","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1161\/CIRCULATIONAHA.104.516898","volume":"112","author":"K Nishiyama","year":"2005","unstructured":"Nishiyama\u00a0K, Takaji\u00a0K, Kataoka\u00a0K, et\u00a0al. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation. 2005;112:2840\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.516898.","journal-title":"Circulation"},{"key":"2208_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095261","author":"X Wang","year":"2022","unstructured":"Wang\u00a0X, Ye\u00a0H, Yang\u00a0S, et al. Disulfiram exerts antifibrotic and anti-inflammatory therapeutic effects on perimysial orbital fibroblasts in graves\u2019 orbitopathy. Int J Mol Sci. 2022; https:\/\/doi.org\/10.3390\/ijms23095261.","journal-title":"Int J Mol Sci"},{"key":"2208_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molimm.2016.03.014","volume":"73","author":"J Yang","year":"2016","unstructured":"Yang\u00a0J, Feng\u00a0S, Yi\u00a0G, et\u00a0al. Inhibition of RelA expression via RNA interference induces immune tolerance in a\u00a0rat keratoplasty model. Mol Immunol. 2016;73:88\u201397. https:\/\/doi.org\/10.1016\/j.molimm.2016.03.014.","journal-title":"Mol Immunol"},{"key":"2208_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00007890-199210000-00026","volume":"54","author":"Y Sonoda","year":"1992","unstructured":"Sonoda\u00a0Y, Streilein\u00a0JW. Orthotopic corneal transplantation in mice\u2014evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694\u2013704. https:\/\/doi.org\/10.1097\/00007890-199210000-00026.","journal-title":"Transplantation"},{"key":"2208_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12929-014-0104-0","volume":"22","author":"M Seo","year":"2015","unstructured":"Seo\u00a0M, Choi\u00a0JS, Rho\u00a0CR, et al. MicroRNA miR-466 inhibits lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model. J\u00a0Biomed Sci. 2015;22:3. https:\/\/doi.org\/10.1186\/s12929-014-0104-0.","journal-title":"J Biomed Sci"},{"key":"2208_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1600-6143.2011.03948.x","volume":"12","author":"M Nosov","year":"2012","unstructured":"Nosov\u00a0M, Wilk\u00a0M, Morcos\u00a0M, et al. Role of lentivirus-mediated overexpression of programmed death-ligand 1 on corneal allograft survival. Am J Transplant. 2012;12:1313\u201322. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03948.x.","journal-title":"Am J Transplant"},{"key":"2208_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/08830180212064","volume":"21","author":"JY Niederkorn","year":"2002","unstructured":"Niederkorn\u00a0JY. Immunology and immunomodulation of corneal transplantation. Int Rev Immunol. 2002;21:173\u201396. https:\/\/doi.org\/10.1080\/08830180212064.","journal-title":"Int Rev Immunol"},{"key":"2208_CR33","doi-asserted-by":"publisher","first-page":"1090877","DOI":"10.3389\/fimmu.2022.1090877","volume":"13","author":"X Fan","year":"2022","unstructured":"Fan\u00a0X, Qiu\u00a0J, Yuan\u00a0T, et\u00a0al. Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation. Front Immunol. 2022;13:1090877. https:\/\/doi.org\/10.3389\/fimmu.2022.1090877.","journal-title":"Front Immunol"},{"key":"2208_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/187221309789257450","volume":"3","author":"Y Shakiba","year":"2009","unstructured":"Shakiba\u00a0Y, Mansouri\u00a0K, Arshadi\u00a0D, et\u00a0al. Corneal neovascularization: molecular events and therapeutic options. Recent Pat Inflamm Allergy Drug Discov. 2009;3:221\u201331. https:\/\/doi.org\/10.2174\/187221309789257450.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"2208_CR35","first-page":"2129","volume":"17","author":"G Liu","year":"2011","unstructured":"Liu\u00a0G, Lu\u00a0P, Li\u00a0L, et al. Critical role of SDF-1alpha-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. Mol Vis. 2011;17:2129\u201338.","journal-title":"Mol Vis"},{"key":"2208_CR36","first-page":"3649","volume":"35","author":"SG Robbins","year":"1994","unstructured":"Robbins\u00a0SG, Mixon\u00a0RN, Wilson\u00a0DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35:3649\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2208_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati\u00a0BK, Nozaki\u00a0M, Singh\u00a0N, et al. Corneal avascularity is due to soluble VEGF receptor\u20111. Nature. 2006;443:993\u20137. https:\/\/doi.org\/10.1038\/nature05249.","journal-title":"Nature"},{"key":"2208_CR38","doi-asserted-by":"publisher","first-page":"e41858","DOI":"10.1371\/journal.pone.0041858","volume":"7","author":"O Xiao","year":"2012","unstructured":"Xiao\u00a0O, Xie\u00a0ZL, Lin\u00a0BW, et al. Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS ONE. 2012;7:e41858. https:\/\/doi.org\/10.1371\/journal.pone.0041858.","journal-title":"PLoS ONE"},{"key":"2208_CR39","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.res.0000022200.71892.9f","volume":"90","author":"I Shiojima","year":"2002","unstructured":"Shiojima\u00a0I, Walsh\u00a0K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90:1243\u201350. https:\/\/doi.org\/10.1161\/01.res.0000022200.71892.9f.","journal-title":"Circ Res"},{"key":"2208_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1096\/fj.201600746R","volume":"31","author":"JK Park","year":"2017","unstructured":"Park\u00a0JK, Peng\u00a0H, Yang\u00a0W, et al. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. FASEB J. 2017;31:256\u201365. https:\/\/doi.org\/10.1096\/fj.201600746R.","journal-title":"FASEB J."},{"key":"2208_CR41","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1111\/jcmm.14621","volume":"23","author":"X Huang","year":"2019","unstructured":"Huang\u00a0X, Ni\u00a0B, Mao\u00a0Z, et\u00a0al. NOV\/CCN3 induces cartilage protection by inhibiting PI3K\/AKT\/mTOR pathway. J\u00a0Cell Mol Med. 2019;23:7525\u201334. https:\/\/doi.org\/10.1111\/jcmm.14621.","journal-title":"J Cell Mol Med"},{"key":"2208_CR42","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fimmu.2018.00925","volume":"9","author":"V Pegoretti","year":"2018","unstructured":"Pegoretti\u00a0V, Baron\u00a0W, Laman\u00a0JD, et al. Selective modulation of TNF-TNFRs signaling: insights for multiple sclerosis treatment. Front Immunol. 2018;9:925. https:\/\/doi.org\/10.3389\/fimmu.2018.00925.","journal-title":"Front Immunol"},{"key":"2208_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal4186","author":"A Hamidi","year":"2017","unstructured":"Hamidi\u00a0A, Song\u00a0J, Thakur\u00a0N, et al. TGF-beta promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85alpha. Sci Signal. 2017; https:\/\/doi.org\/10.1126\/scisignal.aal4186.","journal-title":"Sci Signal"},{"key":"2208_CR44","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1242\/jcs.183764","volume":"129","author":"SM Gross","year":"2016","unstructured":"Gross\u00a0SM, Rotwein\u00a0P. Mapping growth-factor-modulated Akt signaling dynamics. J\u00a0Cell Sci. 2016;129:2052\u201363. https:\/\/doi.org\/10.1242\/jcs.183764.","journal-title":"J Cell Sci"},{"key":"2208_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12886-022-02481-0","volume":"22","author":"J Qian","year":"2022","unstructured":"Qian\u00a0J, Yu\u00a0J, Zhu\u00a0X, et al. MiR-335 promotes corneal neovascularization by targeting EGFR. BMC Ophthalmol. 2022;22:267. https:\/\/doi.org\/10.1186\/s12886-022-02481-0.","journal-title":"BMC Ophthalmol"},{"key":"2208_CR46","doi-asserted-by":"publisher","first-page":"105459","DOI":"10.1016\/j.jsbmb.2019.105459","volume":"194","author":"YN Huo","year":"2019","unstructured":"Huo\u00a0YN, Yeh\u00a0SD, Lee\u00a0WS. Androgen receptor activation reduces the endothelial cell proliferation through activating the cSrc\/AKT\/p38\/ERK\/NFkappaB-mediated pathway. J\u00a0Steroid Biochem Mol Biol. 2019;194:105459. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105459.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2208_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080358","author":"JY Park","year":"2019","unstructured":"Park\u00a0JY, Ji\u00a0YS, Zhu\u00a0H, et al. Anti-angiogenic effect of asperchalasine a via attenuation of VEGF signaling. Biomolecules. 2019; https:\/\/doi.org\/10.3390\/biom9080358.","journal-title":"Biomolecules"},{"key":"2208_CR48","doi-asserted-by":"publisher","first-page":"109156","DOI":"10.1016\/j.biopha.2019.109156","volume":"117","author":"Y Wu","year":"2019","unstructured":"Wu\u00a0Y, Wang\u00a0Y, Nabi\u00a0X. Protective effect of ziziphora clinopodioides flavonoids against H2O2-induced oxidative stress in HUVEC cells. Biomed Pharmacother. 2019;117:109156. https:\/\/doi.org\/10.1016\/j.biopha.2019.109156.","journal-title":"Biomed Pharmacother"},{"key":"2208_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11010-018-3475-9","volume":"455","author":"Q Cao","year":"2019","unstructured":"Cao\u00a0Q, Lu\u00a0W, Zhou\u00a0T, et al. Analgesic-antitumor peptide inhibits angiogenesis by suppressing AKT activation in hepatocellular carcinoma. Mol Cell Biochem. 2019;455:119\u201325. https:\/\/doi.org\/10.1007\/s11010-018-3475-9.","journal-title":"Mol Cell Biochem"},{"key":"2208_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s12276-022-00778-0","volume":"54","author":"Z Zhao","year":"2022","unstructured":"Zhao\u00a0Z, Zhang\u00a0Y, Zhang\u00a0C, et al. TGF-beta promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2\/3 and Akt\/mTOR pathways. Exp Mol Med. 2022;54:673\u201384. https:\/\/doi.org\/10.1038\/s12276-022-00778-0.","journal-title":"Exp Mol Med"},{"key":"2208_CR51","doi-asserted-by":"publisher","first-page":"4290922","DOI":"10.1155\/2022\/4290922","volume":"2022","author":"Y Yang","year":"2022","unstructured":"Yang\u00a0Y, Jin\u00a0H, Qiu\u00a0Y, et\u00a0al. Reactive oxygen species are essential for placental angiogenesis during early gestation. Oxid Med Cell Longev. 2022;2022:4290922. https:\/\/doi.org\/10.1155\/2022\/4290922.","journal-title":"Oxid Med Cell Longev"},{"key":"2208_CR52","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1038\/onc.2016.56","volume":"35","author":"II Lee","year":"2016","unstructured":"Lee\u00a0II, Maniar\u00a0K, Lydon\u00a0JP, et al. Akt regulates progesterone receptor B\u2011dependent transcription and angiogenesis in endometrial cancer cells. Oncogene. 2016;35:5191\u2013201. https:\/\/doi.org\/10.1038\/onc.2016.56.","journal-title":"Oncogene"},{"key":"2208_CR53","doi-asserted-by":"publisher","first-page":"25870","DOI":"10.1038\/srep25870","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen\u00a0J, Chen\u00a0P, Backman\u00a0LJ, et al. Ciliary neurotrophic factor promotes the migration of corneal epithelial stem\/progenitor cells by up-regulation of MMPs through the phosphorylation of Akt. Sci Rep. 2016;6:25870. https:\/\/doi.org\/10.1038\/srep25870.","journal-title":"Sci Rep"},{"key":"2208_CR54","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.ajpath.2021.07.010","volume":"191","author":"Y Liu","year":"2021","unstructured":"Liu\u00a0Y, Di\u00a0G, Wang\u00a0Y, et\u00a0al. Aquaporin 5 facilitates corneal epithelial wound healing and nerve regeneration by reactivating Akt signaling pathway. Am J Pathol. 2021;191:1974\u201385. https:\/\/doi.org\/10.1016\/j.ajpath.2021.07.010.","journal-title":"Am J Pathol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02208-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T20:07:11Z","timestamp":1710619631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02208-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":54,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02208-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"X.\u00a0Wang and P.\u00a0Wang declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted and approved by the Institutional Review Board of Chongqing Medical University, the First Affiliated Hospital of Chongqing Medical University (Approval No. 20190956). We confirm that all methods were carried out in accordance with relevant guidelines and regulations, and we also guarantee that all procedures are reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}